FDA Expands Pediatric Suicidality Caution To Antidepressants Beyond Paxil

FDA is expanding its concerns about the suicide potential of antidepressants in pediatric patients beyond GlaxoSmithKline's Paxil

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet